ClinicalTrials.gov
public full text
Public Domain
Infliximab Top-down in Pediatric Crohn
The purpose of this study is to determine whether a top-down treatment approach, prescribing infliximab and azathioprine at diagnose, yields better outcome in comparison to the usual step-up treatment approach, starting with prednison and azathioprine, in moderate-to-severe pediatric Crohn's disease (CD) patients.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- The Therapy Effect of Azathioprine Initial or 14 Weeks After Combined With Infliximab on CD#887783
- Medical Treatment Versus Surgery in Stricturing Small Bowel Crohn's Disease#837327
- Efficacy and Safety of Top-down Therapy in Pediatric Crohn's Disease#827285
- The Efficacy and Safety of Infliximab Combination With Azathioprine in Crohn's Disease in Children#879069
- Induction Optimization With Stelara for Crohn's Disease#1163187
Record · ID 887274
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive